The first patient-reported outcomes from the Utrecht Prostate Cohort (UPC): the first platform facilitating ‘trials within cohorts’ (TwiCs) for the evaluation of interventions for prostate cancer - Takeaways - MDSpire

The first patient-reported outcomes from the Utrecht Prostate Cohort (UPC): the first platform facilitating ‘trials within cohorts’ (TwiCs) for the evaluation of interventions for prostate cancer

  • By

  • Frederik R. Teunissen

  • Thomas Willigenburg

  • Richard P. Meijer

  • Harm H. E. van Melick

  • Helena M. Verkooijen

  • Jochem R. N. van der Voort van Zyp

  • July 21, 2022

  • 0 min

Share

  • 1

    Prostate cancer is the most common cancer in men, with over 1.4 million new cases reported globally in 2020.

  • 2

    The Utrecht Prostate Cohort (UPC) facilitates trials within cohorts (TwiCs) for evaluating new prostate cancer treatments.

  • 3

    UPC aims to create a real-life data infrastructure for assessing clinical and patient-reported outcomes in prostate cancer.

  • 4

    Patients in UPC provide informed consent for data collection and potential random allocation to experimental treatments.

  • 5

    The study collects comprehensive clinical data and patient-reported outcomes to enhance the evaluation of prostate cancer interventions.

Original Source(s)

The first patient-reported outcomes from the Utrecht Prostate Cohort (UPC): the first platform facilitating ‘trials within cohorts’ (TwiCs) for the evaluation of interventions for prostate cancer

  • by Frederik R. Teunissen, Thomas Willigenburg, Richard P. Meijer, Harm H. E. van Melick, Helena M. Verkooijen, Jochem R. N. van der Voort van Zyp

  • July 21, 2022

Related Content

Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: a systematic review and meta-analysis

Predicting post-radiation genitourinary hospital admissions in patients with localised prostate cancer

Optimizing Outcomes: How Multidisciplinary Approaches Improve Prostate Cancer Survival Rates

Prostate cancer management has evolved significantly over the years, propelled by groundbreaking diagnostics and advancements in treatment modalities.

  • by

  • March 18, 2024

  • 4 min